Results 181 to 190 of about 25,148 (262)

Impact of Low‐Dose Cranberry Polyphenols on Gut Microbiota and Circulating Polyphenol Metabolites in Overweight and Obese Individuals (A Randomized Double‐Blind Placebo‐Controlled Clinical Pilot Study)

open access: yesFood Science &Nutrition, Volume 14, Issue 6, June 2026.
The health‐promoting effects of cranberry are largely attributed to its polyphenol content, which is known to reach the colon in largely unmetabolized form. The cranberry group significantly elevated catechol‐O‐sulfate levels compared to the placebo group.
Maria Jocelyn Chicas Castellon   +6 more
wiley   +1 more source

Structured integration of rapid antimicrobial susceptibility testing and antimicrobial resistance detection into an antimicrobial stewardship programme for bacteraemia. [PDF]

open access: yesJAC Antimicrob Resist
Halperin AV   +7 more
europepmc   +1 more source

From Plate to Patient: A Systematic Review of Food‐Related Campylobacteriosis Case Reports

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Campylobacteriosis, primarily caused by Campylobacter jejuni, C. coli, and C. fetus, remains the leading bacterial cause of foodborne gastroenteritis globally, with increasing incidence in both developed and developing nations.
Minoo Moghimani   +3 more
wiley   +1 more source

Retrospective Evaluation of Dual Specialty Ports in Therapeutic Apheresis

open access: yesJournal of Clinical Apheresis, Volume 41, Issue 3, June 2026.
ABSTRACT Dual specialty ports were evaluated for safety and efficacy in therapeutic apheresis by analyzing outcomes across 97 port placement events in 88 patients, focusing on two configurations: dual Bard PowerFlow (BP2) and a combination of Bard PowerFlow with AngioDynamics SmartPort (BP + AD).
Mugtaba Swar‐Eldahab   +3 more
wiley   +1 more source

Fosfomycin versus ciprofloxacin for febrile neutropenia prophylaxis in high-risk haematological patients (FOVOCIP): a phase 3, open-label, multicentre, randomised, non-inferiority trial. [PDF]

open access: yesLancet Reg Health Eur
Moreno AF   +28 more
europepmc   +1 more source

Categorization of Reasons for Hospitalizations in Patients With Cutaneous T‐Cell Lymphoma

open access: yesJEADV Clinical Practice, Volume 5, Issue 2, Page 624-626, June 2026.
ABSTRACT Background Cutaneous T‐cell lymphomas (CTCL) can significantly impact patients' quality of life as well as impose a substantial healthcare burden due to their complex management and risk of hospitalization. Objectives This study aimed to identify factors associated with hospital admissions among patients with CTCL and to characterize the ...
Geetha Gowda   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy